Veränderungen von Plättchenfunktion und plasmatischer Gerinnung bei Diabetes mellitus

H. K. Breddin; H. J. Krzywanek

doi:10.1055/s-0038-1656629

Hämostaseologie, Table of Contents

Hamostaseologie 1983; 03(04): 131-139
DOI: 10.1055/s-0038-1656629

Originalarbeiten

Schattauer GmbH

Veränderungen von Plättchenfunktion und plasmatischer Gerinnung bei Diabetes mellitus

H. K. Breddin

¹Aus dem Zentrum der Inneren Medizin, Abteilung für Angiologie der Johann-Wolfgang-Goethe-Universität, Frankfurt am Main

,

H. J. Krzywanek

› Author Affiliations

Abstract

Full Text

References

LITERATUR
1 Abastado M, Donmenc J, Prost R, Bara L, Samama M, Derot M, Bousser J. Etude de l’activité fibrinolytique et des fonctions plaquettaires dans le premier temps de l’hémostase chez les diabetiques. Presse médical 1968; 76: 1317-1320.
2 Abrahamsen A. F. Platelet survival studies in man. Scand. J. Haemat., Suppl. 1968: 3
3 Aimer L. O, Pandolfi M, Nilsson I. M. Diabetic retinopathy and the fibrinolytic system. Diabetes 1975; a 24 (15) S.529-534.
4 Aimer L. O, Nilsson J. M. On fibrinolysis in diabetes mellitus. Acta med. Scand 1975; b 198: 101-106.
5 Aimer L. O, Pandolfi M. Fibrinolysis and diabetic retinopathy. Diabetes 1976; 25 NR. Suppl (Suppl. 02) S.807-810.
6 Almer L. O. The fibrinolytic system in diabetes mellitus. Sixth Congr. on Thrombosis of the mediterranean league against thromboembolic diseases, Monte Carlo, Abstr. 1980: 120
7 Aimer L. O, Sundkvist G, Lilja B. Endothelial factors, the temperature and leg circulation in diabetics with and without autonomic neuropathy. Thrombos. Res 1982; 26: 119-128.
8 Badawi H, El-Sawy M, Mikhail M, Nomeiri A. M, Tewfik S. Platelets, coagulation and fibrinolysis in diabetic and nondiabetic patients with quiescent coronary heart disease. Angiology 1970; 21: 511-519.
9 Banerjee R. N, Sahni A. L, Kumar V. Fibrinocoagulopathy in maturity onset diabetes mellitus and atherosclerosis. Thrombos. Diathes. Haemorrh 1973; 30: 123-132.
10 Banerjee R. N, Sahni A. L, Kumar V, Arya M. Antithrombin III deficiency in maturity onset diabetes mellitus and atherosclerosis. Thrombos. Diathes. Haemorrh 1974; 31: 339-345.
11 Bender N, Ziemen M, Friedrich J, Kirchmaier C. Erhöhter Beta-Thromboglobulinspie-gel im Plasma von Diabetikern und von Patienten mit arterieller Verschlußkrankheit. In Schmipf K. (Hrsg.) Fibrinogen, Fibrin und Fibrinkleber. Nebenwirkungen der Therapie mit Gerinnungsfaktorenkonzentraten S.535-540. Schattauer; Stuttgart – New York: 1980
12 Bensoussan D, Levy-Toledano S, Passa P, Caen J, Canivet J. Platelet hyperaggregation and increased plasma level of von Willebrand factor in diabetics with retinopathy. Diabetologia 1975; 11: 307-312.
13 Bern M. M. Platelet functions in diabetes mellitus. Diabetes 1978; 27: 342-350.
14 Bern M. M, Rand L, Peirce C, Fraser M, Erickson S, White K, Arkin C, Gallavan M. Effects of platelet function, Factor VIII, v. Willebrand’s factor and fibrinolysis on development of diabetic retinopathy after long term diabetes mellitus. Monte Carlo, Sixth Congr. on thrombosis of the mediterranean, league against thromboembolic diseases. Abstr. 1980: 158
15 Bern M. M, Cassani M. P, Horton J, Rand L, Davis G. Changes of fibrinolysis and factor VIII coagulant, antigen and ristocetin cofac-tor in diabetes mellitus and atherosclerosis. Thrombos. Res 1980; 19: 831-839.
16 Bizzi B, Leone G, Boni P. Basic considerations on treatment of increased platelet aggregation in diabetic vasculopathic patients. Acta diabet. lat 1974; 11: 437-445.
17 Borkenstein M. H, Muntean W. E. Elevated factor VIII activity and factor VHI-related antigen in diabetic children without vascular disease. Diabetes 1982; 31: 1006-1009.
18 Borsey D. Q, Dawes J, Fraser D. M, Prowse C. V, Elton R. A, Clarke B. F. Plasma beta-thromboglobulin in diabetes mellitus. Diabetologia 1980; 18: 353-357.
19 Breddin K. Über die gesteigerte Thrombozy-tenagglutination bei Gefäßkrankheiten. Schweiz. med. Wschr 1965; 95: 655-660.
20 Breddin K. Thrombozytenagglutination bei Gefäßkrankheiten. Med. Welt 1966; 17: 2322-2324.
21 Breddin K, Krzywanek H. J, Ziemen M. Enhanced platelet aggregation as a risk factor for vascular disease and its thromboembolic complications. Acta clin. Belg 1975; 30: 195-203.
22 Breddin K, Bauke J. Thrombozytenagglutination und Gefäßkrankheiten. 1965; Blut 11: 144-164.
23 Breddin K, Krzywanek H. J, Ziemen M. Methods for the evaluation of the risk of thrombosis in patients with atherosclerosis. Rome, Ed. C. E. P. S., 1976, in: Advances in coagulation, fibrinolysis, platelet aggregation and atherosclerosis. S. 124-139.
24 Breddin K, Grun H, Krzywanek H. J, Schremmer P. On the measurement of spontaneous platelet aggregation. The platelet aggregation test III. Methods and first clinical results. Thrombos. Haemostas 1976; 35: 669-691.
25 Breddin K, Krzywanek H. J. Thrombocyte function and age. Studies with healthy volunteers, diabetics and patients with vascular disease. In Effert S, Meyer-Erkelenz J. D. (Eds.) Problems arising at the borders of natural and artificial blood vessels Springer; Berlin – Heidelberg – New York: 1976: S. 43-50.
26 Brooks A. M. V, Hussein S, Chesterman C. N, Martin J. F, Alford F. P, Penington D. G. Platelets, coagulation and fibrinolysis in patients with diabetic retinopathy. Thromb. Haemostas 1983; 49: 123-127.
27 Burrows A. W, Chavin S. I, Hockaday T. D. R. Plasma-Betathromboglobulin concentrations in diabetes mellitus. Lancet 1978; 1: 235-237.
28 Cagliero E, Porta M, Cousins S, Kohner E. M. Increased platelet volume in diabetic retinopathy. Haemostasis 1982; 12: 293-299.
29 Campbell I. W, Dawes J, Fraser D. M, Pepper D. S, Clarke B. F, Duncan L. J. P, Cash J. D. Plasma beta-thromboglobulin in diabetes mellitus. Diabetes 1977; 26: 1175-1177.
30 Cash J. D, McGill R. C. Fibrinolytic response to moderate exercise in young male diabetics and non-diabetics. J. Clin. Path 1969; 22: 32-35.
31 Coccheri S, Palareti G, Poggi M. Hemorheology and blood clotting in diabetic retinopathy. Monte Carlo, Sixth Congr. on Thrombosis of the mediterranean league against thromboembolic diseases. Abstr. 1980: 157
32 Coller B. S, Frank R. M, Milton R. C, Gralnick H. R. Plasma cofactors of platelet function: Correlation with diabetic retinopathy and hemoglobins A 1 a–c. Ann. Intern. Med 1978; 88: 311-316.
33 Colwell J. A, Chambers A, Laimins M. Inhibition of labile aggregation-stimulating substance (LASS) and platelet aggregation in diabetes mellitus. Diabetes 1975; 24: 684-687.
34 Colwell J. A, Halushka P. V, Sarji K, Levine J, Sagel J, Raghavani C. B, Nair M. G. Altered platelet function in diabetes mellitus. Diabetes 1976; 25 Suppl (Suppl. 02) 826-831.
35 Colwell J. A, Sagel J, Crook L, Chambers A, Laimins M. Correlation of platelet aggregation, plasma factor activity, and megathrom-bocytes in diabetic subjects with and without vascular disease. Metabolism 1977; 26: 279-285.
36 Colwell J. A, Halushka P. V, Sarji K. E, Sagel J. Platelet function and diabetes mellitus. Med. clin. J. Amer 1978; 62: 753-766.
37 Colwell J. A, Gonzalez J, Sarji K. E, Sarji R. M. G, Sagel J. Effect of metabolic control with insulin on plasma von Willebrand factor activity, growth hormone, and platelet aggregation in diabetes mellitus. Thromb. Haemostas 1979; 42: 382
38 Colwell J. A, Halushka P. V, Sarji K. E, Lopes-Virella M. F, Sagel J. Vascular disease in diabetes. Pathophysiological mechanisms and therapy. Arch. intern. Med 1979; 139: 225-230.
39 Colwell J. A, Nair R. M, Halushka P. V, Rogers C, Whetsell A, Sagel J. Platelet adhesion and aggregation in diabetes mellitus. Metabolism 1979; 28: 394-400.
40 Colwell J. A, Halushka P. V. Platelet function in diabetes mellitus. Brit. J. Haemat 1980; 44: 521-526.
41 Corbella E, Miragliotta G, Masperi R, Villa S, Binio A, de Gaetano G, Chiumello G. Platelet aggregation and antithrombin III levels in diabetic children. Haemostasis 1979; 8: 30-37.
42 Corrall R. J. M, Webber R. G, Frier B. M. Increase in coagulation factor VIII activity in man following acute hypoglycaemia: mediation via an adrenergic mechanism. Brit. J. Haemat 1980; 44: 301-305.
43 Cretar D, Parlotzky F, Savir H. Platelet aggregation in diabetic retinopathy. Acta haemat 1978; 60: 53-55.
44 D’Angelo A, Micossi P, Franchi F, Mannucci P. M. Production of platelet thromboxane B2 in non-insulin dependent diabetics: inhibition of the arachidonate enzymatic pathway in diabetic microangiopathy. Haemostasis 1982; 12: 89
45 Dalsgaard-Nielsen J, Madsbad S, Hilsted J. Changes in platelet function, blood coagulation and fibrinolysis during insulin-induced hypoglycaemia in juvenile diabetics and normal subjects. Thromb. Haemostas 1982; 47: 254-258.
46 Dassin E, Najean Y, Poirier O, Passa Ph, Bensoussan D. In vivo platelet kinetics in 31 diabetic patients. Correlation with the degree of vascular impairment. Thromb. Haemostas 1978; 40: 83-88.
47 Davi G, Rini G. B, Averna M, Novo S, Di Fede G, Mattina A, Notarbartolo A, Strano A. Enhanced platelet release reaction in insulin-dependent and insulin-independent diabetic patients. Haemostasis 1982; 12: 275-281.
48 Davis J. W, Phillips P. E, Yue K. T. N, Lewis jr. H. D, Hartman C. R. Platelet aggregation. Adult-onset diabetes mellitus and coronary artery disease. JAMA 1978; 239: 732-734.
49 Egeberg O. The blood coagulability in diabetic patients. Scand. J. Clin. Lab. Invest 1963; 15: 533-538.
50 Elder G. E, Mayne E. E, Daly J. G, Kennedy A. L, Hadden D. R, Montgomery D. A. D, Weaver J. A. Antithrombin III activity and other coagulation changes in proliferative diabetic retinopathy. Haemostasis 1980; 9: 288-296.
51 Fearnley G. R, Chakrabarti R, Davis P. R. Blood fibrinolytic activity in diabetes mellitus and its bearing on ischemic heart disease and obesity. Brit. Med. J 1963; I: 921-923.
52 Ferguson J. C, Mackay N, Philip J. A. D, Summer D. J. Platelet and fibrinogen kinetic studies in diabetes mellitus. Brit. J. Haemat 1973; 25: 545
53 Ferguson J. C, Mackay N, Philips A. O, Summer D. J. Determination of platelet and fibrinogen half-life with (75-Se) selenomethionine; studies in normal and in diabetic subjects. Clin. Sci. Molec. Med 1975; 49: 115-120.
54 Fleischmann A. B, Bierenbaum M. L, Stier A, Somol H, Watson P. B. In vivo platelet function in diabetes mellitus. Thrombos. Res 1976; 9: 467-471.
55 Fuller J. H, Keen H, Jarrett R. J, Orner T, Meade T. W, Chakrabarti R, North W. R. S, Stierling Y. Haemostatic variables associated with diabetes and its complications. Brit. Med. J 1979; 2: 964-966.
56 Fuller J. H, Meade T. W, Keen H, Chakrabarti R, Jarrett R. J, North W. R. S, Omer T, Stierling Y. Haemostasis in diabetes and its relationship with diabetic complications. (Abstr.). Thrombos. Haemostas 1979; 42: 383
57 Gamba C, Grignani G, Pacchiarini L, Geroldi D, Solerete B. S. Haemostatic abnormalities in diabetics with and without thromboembolic complications. Haemostasis 1982; 12: 164
58 Ganda O. P. Pathogenesis of macrovascular disease in the human diabetic. Diabetes 1980; 29: 931-942.
59 Gandolfo G. M, De Angelis A, Torresi M. V. Determination of Antithrombin III activities by different methods in diabetic patients. Haemostasis 1980; 9: 15-19.
60 Garcia-Conde J, Amado J. A, Merino J, Benet J. Prostaglandins and platelet function in diabetes. Thrombos. Haemostas 1979; 42: 335
61 Gensini G. F, Abbate R, Favilla S, Neri Serneri G. G. Changes of platelet function and blood clotting in diabetes mellitus. Thromb. Haemostas 1979; 42: 983-993.
62 Gerrard J. M, Stuart M. J, Rao G. H. R, Steffes M. W, Mauer S. M, Brown D. M, White J. G. Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J. Lab. clin. Med 1980; 95: 950-958.
63 Giustolisi R, Lombardo R, Musso R, Cacciola E. Factor VIII antigen plasma levels in diabetes mellitus. Enhanced endothelial release and storage. Thromb. Haemostas 1980; 44: 46
64 Giustolisi R, Lombardo R, Musso R, Cacciola E. Possible evidence for an increased factor VIII antigen synthesis in vascular endothelium of diabetic subjects. Thromb. Haemostas 1982; 47: 293
65 Grignani G, Gamba G, Biancardi M, Geroldi D, Ferrari E, Bossolo P. A, Cinquini C, de Narco R. Studies of the prethrombotic state of patients with maturity-onset diabetes mellitus undergoing different hypoglycemic treatments. Thromb. Haemostas 1979; 42: 486
66 Grignani G, Gamba G, Geroldi D, Pacchiarini L, Solerte B, Ferrari E, Ascari E. Enhanced antithrombotic mechanisms in patients with maturity-onset diabetes mellitus without thromboembolic complications. Thromb. Haemostas 1981; 46: 648-651.
67 Gurewich V, Lipinska I, Pulini M, Gordon E, Lipinski B. Fibrinogen, fibrinogen heterogeneity and fibrinolytic activity in diabetes mellitus. Thromb. Haemostas 1977; 38: 103
68 Gurewich V, Lipinska I. Lower molecular weight fibrinogen and non-clottable fibrinogen derivatives in diabetes mellitus. Thrombos. Res 1981; 22: 533-541.
69 Halushka P. V, Lurie D, Colwell J. A. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus. New Engl. J. Med 1977; 297: 1306-1310.
70 Halushka P. V, Rogers R. C, Loadholt C. B, Colwell J. A. Increased platelet thromboxane synthesis in diabetes mellitus. J. Lab. clin. Med 1981; 97: 87-96.
71 Harrison H. E, Reece A. H, Johnson M. Effect of insulin treatment on prostacyclin in experimental diabetes. Diabetologia 1980; 18: 65-68.
72 Hassanein A, El-Garf A, El-Baz Z. Platelet aggregation in diabetes mellitus and effect of insulin in vivo on aggregation. Thrombos. Diathes. Haemorrh 1972; 27: 114-120.
73 Heath H, Bridgen W. D, Canever J. V, Pollock J, Hunter P. R, Kelsey J. Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia 1971; 7: 308-315.
74 Heischmann A. J, Bierenbaum M. L, Stier A, Somol S. H, Watson P. B. In vivo platelet function in diabetes mellitus. Thromb. Res 1976; 9: 467
75 Hellem A. J. Adenosine diphosphate induced platelet adhesiveness in diabetes mellitus with complications. Acta med. Scand 1971; 190: 291-295.
76 Janka H. U, Standi E. Thrombozytenaggregation im diabetischen Koma: Beziehungen zum Gehalt von zyklischem AMP und zur Prostazyklin stimulierbaren Adenylatzyklase-Aktivität der Thrombozyten. Intensivmed 1979; 16: 275-277.
77 Johnson M, Harrison H. E, Raftery A. R, Elder J. B. Vascular prostacyclin may be reduced in diabetics in man. Lancet 1979; 1: 325-326.
78 Jones R. L, Peterson Ch. M. Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon. J. Clin. Invest 1979; 63: 485-493.
79 Kazmier F. J, Owen Ch.A, O’Fallon W. M, Palumbo P. J, Bowie E. J. W. Willebrand antigen (VIII R:Ag) and ristocetin-cofactor (VIII :RWF) in atherosclerosis and diabetes mellitus. Circulation, Suppl 1979; 2: S. 1060
80 Kazmier F. J, Fuster V, Chesebro J. H, O’Fallon W. M, Palumbo P. J. Platelet survival half-life in diabetes mellitus with and without peripheral arterial occlusion disease. Thromb. Haemostas 1979; 42: 384
81 Kazmier F. J, Bowie E. J. W, O’Fallon W. M, Palumbo P. J. Platelet factor 4 (PG4) and beta-thromboglobulin (beta-TG) in atherosclerosis and diabetes mellitus. Thrombos. Haemostas 1981; 46: S.79 Abstr
82 Kreuz W, Jung R, Kollmann F. Veränderungen der Hämostase bei Kindern mit Diabetes. In Vorbereitung. 1983
83 Krzywanek H. K, Breddin K, Scharrer I, Kutschera J. Enhanced platelet aggregation as a risk factor for thromboembolic complications in atherosclerosis?. In Schettler G, Weizel A. (Eds) Atherosclerosis III 283-285. Springer; Berlin – Heidelberg – New York: 1974
84 Krzywanek H. J. Gesteigerte Plättchenaggre-gation im PAT am Beispiel des Diabetes mellitus. Korrelation dieser Befunde mit den Ergebnissen anderer Aggregationstests. In Breddin H. K. (Ed.) Prostaglandine und Plattchenfunktion Schattauer; Stuttgart – New York: 1978: 127-133.
85 Krzywanek H. J, Coutandin K, Friedrich J, Breddin K. PARD – A prospective study on the development of vascular complications in diabetics. Thromb. Haemostas 1979; 42: 484
86 Krzywanek H. J, Ziemen M, Weichert W. PARD – Platelet aggregation: A risk factor in diabetes mellitus. Monte Carlo, Sixth Congr. on thrombosis of the league against thromboembolic diseases. 1980: S. 160
87 Kwaan H. C, Colwell J. A, Suwanwela N. Disseminated intravascular coagulation in diabetes mellitus, with reference to the role of increased platelet aggregation. Diabetes 1972; 21: 108-113.
88 Kwaan H. C, Colwell J. A, Cruz S, Suwanwela N, Dobbie J. G. Increased platelet aggregation in diabetes mellitus. J. Lab. clin. Med 1972; 80: 236-247.
89 Lagarde M, Burtin M, Berciaud P, Blanc M, Velardo B, Dechavanne M. Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. Thrombos. Res 1980; 19: 823-830.
90 Lars-Olof A, Nilsson J. M. On fibrinolysis in diabetes mellitus. Acta Med. scand 1975; 298: 101-106.
91 Lecrubier C, Scarabin P. Y, Grauso F, Samama M. Platelet aggregation related to age in diabetes mellitus. Haemostasis 1980; 9: 43-51.
92 Lee H, Paton R. C, Passa P, Caen J. P. Fibrinogen binding and ADP-induced aggregation in platelets from diabetic subjects. Thrombos. Res 1981; 24: 143-150.
93 Levin R. D, Kwaan H. C, Dobbie J. G, Fetkenhour D. L, Traisman H. S. Partial purification and studies of the plasma cofactor that potentiates platelet aggregation in diabetes mellitus. J. Lab. clin. Med 1981; 98: 519-526.
94 Lipinska I, Lipinski B, Gurewich V. Reversible inhibition of euglobulin fibrinolytic activity in diabetes mellitus. Thromb. Haemostas 1979; 42: 382 Abstr
95 Lucic A, Lepsanovic L, Kulauzov M, Bukvic R. The values of platelet factor 4 in diabetic patients before and after the isometric exercise. Thrombos. Haemostas 1981; 46: 440
96 Lufkin E. G, Fass D. N, O’Fallon W. M, Bowie E. J. W. Increased von Willebrand factor in diabetes mellitus. Metabolism 1979; 28: 63-66.
97 Masperi R, Mussoni L, Bini A, Donati M. B, Chiumello G. Haemostatic variables in uncomplicated diabetic children. Thromb. Haemostas 1980; 43: 227
98 Matsuo T, Ohki Y. Classification of platelet aggregation patterns with two ADP solutions (the double-ADP method) and its clinical application to diabetes mellitus. Thrombos. Res 1977; 77: 453-461.
99 Matthews J. H, O’Connor J. F, Hearn-shaw J. R, Wood J. K. Beta-thromboglobulin and glycosylated haemoglobin in diabetes mellitus. Scand. J. Haemat 1979; 23: 421-426.
100 Mayne E. E, Bridges J. M, Weaver J. A. Platelet adhesiveness, plasma fibrinogen and Factor VIII levels in diabetes mellitus. Diabetologia 1970; 6: 436-440.
101 McDonald J. W. D, Dupre J, Rodger N. W, Champion M. C, Webb C. D, Ali M. Comparison of platelet thromboxane synthesis in diabetic patients on conventional insulin therapy and continuous insulin infusions. Thrombos. Res 1982; 28: 705-712.
102 Mustard J. F, Packham M. A. Platelets and Diabetes mellitus. New Engl. J. Med 1977; 297: 1345-1347.
103 Nenci G. G, Merante F, Agnelli G, Ballatori E. Aggregazione piastrinica spontanea in vivo e in vitro nei diabetici e nei vasculopatici. Catania, 1980, 6. Congr. Naz. Soz. Ital. Studio d Emostasi e trombosi., Abstr.
104 Nordöy A, Rödset J. M. Platelet phospholipids and their function in patients with juvenile diabetes and maturity onset diabetes. Diabetes 1970; 19: 698-702.
105 O’Malley B. C, Ward J. D, Timperley W. R, Porter N. R, Preston F. E. Platelet abnormalities in diabetic peripheral neuropathy. Lancet 1975; 2: 1274-1276.
106 Ødegaard A. E, Skalhegg B. A, Hellem A. J. Increased activity of »anti-Willebrand-factor« in diabetic plasma. Thrombos. Diathes. Haemorrh 1964; 21: 27-37.
107 Oost B. A. van, Veldhuyzen B. F. E, van Houwelingen H. C, Timmermans A. P. M, Sixma J. J. Tests for platelet changes, acute phase reactants and serum lipids in diabetes mellitus and peripheral vascular disease. Thrombos. Haemostas. (Stuttgart) 1982; 48: 289-293.
108 Pandolfi M, Almer L.-O, Holmberg L. Increased von Willebrand-antihaemophilic factor A in diabetic retinopathy. Acta Ophthal 1974; 52: 823-828.
109 Pannebakker M. A. G, Jonker J. J. C, de Boer A. C, den Ottolander G. J. H. Platelet function tests in relation to retinopathy and neuropathy in well controlled diabetic patients. Thrombos. Haemostas 1979; 42 S. Abstr 335
110 Pareti F. I, Gugliotta L, Mannucci L, Guarini A, Mannucci P. M. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders. Thromb. Haemostas 1982; 47: 84-89.
111 Passa P, Bensoussan D, Levy-Toledano S. Etude de l’aggregation plaquettaire au cours de la retinopathie diabetique. Influence de l’hypophysectomie. Atherosclerosis 1974; 19: 277-285.
112 Paton R. C. Platelet survival in diabetes mellitus using an aspirin-labelling technique. Thrombos. Res 1979; 15: 793-802.
113 Peterson H. D, Gormsen J. Platelet aggregation in diabetes mellitus. Acta med. scand 1978; 203: 125-130.
114 Pietsch U, Krzywanek H. J, Breddin K. Ist das Aggregationsverhalten der Thrombozyten ein Indikator für das Fortschreiten athe-rosklerotischer Gefäßwandprozesse bei Diabetikern? Diab. Angiopathien. 1976: S. 229-235.
115 Pietsch U, Krzywanek H. J, Breddin H. K. Ist das Aggregationsverhalten der Thrombozyten ein Indikator für das Fortschreiten athe- rosklerotischer Gefäßwandprozesse bei Diabetikern?. In Alexander K, Cachovan M. (Hrsg.) Diabetische Angiopathien 1977: S. 229-235. Witzstrock; Baden-Baden, Köln, New York, Brüssel:
116 Porta M, Hilgard P, Kohner E. Adenosine diphosphate-induced platelet shape change in normal and diabetic subjects. Clin. sci 1979; 57: 24
117 Porta M, McCraw A, Kohner F. M. Inverse relationship between ristocetin co-factor levels and platelet aggregation in insulin dependent diabetes. Thrombos. Res 1982; 25: 507-512.
118 Preston F. E, Ward J. D, Marcola B. H, Porter N. R, Timperley W. R. Elevated ß-throm-boglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet 1978; 2: 238-239.
119 Rak K, Beck P, Udvardy M, Pflieger G, Misz M, Boda Z. Plasma levels of beta-throm-boglobulin and factor VIII related antigen in diabetic children and adults. Thrombos. Res 1983; 29: 155-162.
120 Rathbone R. L, Ardlie N. G, Schwartz C. J. Platelet aggregation and thrombus formation in diabetes mellitus, an in vitro study. Pathology 1970; 2: 307-316.
121 Rouse E, Cherbit G, Regnault F. Collagen-induced platelet aggregation and collagen glycosyl-transferase activity in diabetic patients. Thrombos. Res 1977; 11: 847-858.
122 Sagel J, Colwell J. A, Crook L, Laimins M. Increased platelet aggregation in early diabetes mellitus. Ann. Int. Med 1975; 82: 733-738.
123 Sarji K. E, Lushbaugh W. B, Halushka P. V, Humphrey C. D, Pittman F. E, Gale G. R, Colwell J. A. Action of arachidonic acid on platelets from diabetic and normal subjects. Clin. Res 1977; 25: 53 a
124 Scarpello J. H. B, Best L. C, Marcola B. H, McGuire M. B, Preston F. E, Russel R. G. G, Ward J. D. Platelet function studies in diabetics with peripheral neuropathy. Thrombos. Haemostas 1979; 42: 383 (Abstr.)
125 Scharrer I, Lenz M, Maas C. The behavior of ristocetin cofactor, F. VIII related antigen, inhibitors of coagulation and platelet aggregation in diabetes. Thrombos. Haemostas 1979; 42: 439
126 Sharma M. S. C. Platelet adhesiveness in juvenile onset and maturity onset diabetes mellitus. Thromb. Haemostas 1981; 45: 297
127 Shaw S, Pegrum G. D, Wolff S, Ashton W. L. Platelet adhesiveness in diabetes mellitus. J. clin. Path 1967; 20: 845-847.
128 Silberbauer K, Schernthaner G, Sinzinger H, Winter M, Piza-Katzer H. Juveniler Diabetes mellitus: Verminderte Prostacyclin (PG₁₂)Synthese in der Gefäßwand. VASA 1979; 8: 213-216.
129 Silberbauer K, Schernthaner G, Sinzinger H, Piza-Katzer H, Winter M. Decreased vascular prostacyclin in juvenile-onset diabetes. New Engl. J. Med 1979; 300: 366-367.
130 Stuart M. J, Murphy B. S. S, Oski F. A. A simple nonradioisotope technic for the determination of platelet life-span. New Engl. J. Med 1975; 1: 1310-1312.
131 Szirtes M. Platelet aggregation in diabetes mellitus. Adv. Cardiol 1970; 4: 179-186.
132 Takeda H, Maeda H, Fukushima H, Nakamura N, Uzawa H. Increased platelet phospholipase activity in diabetic subjects. Thrombos. Res 1981; 24: 131-141.
133 Tanser A. R. Fibrinolytic response of diabetics and non-diabetics to adrenaline. J. Clin. Path 1967; 20: 231-233.
134 Tindall H, Paton R. C, Zuzel M, McNicol G. P. Platelet life-span in diabetics with and without retinopathy. Thrombos. Res 1981; 21: 641-648.
135 Tsianos E. B, Stathakis N. E. Soluble fibrin complexes and fibrinogen heterogeneity in diabetes mellitus. Thromb. Haemostas 1980; 44: 130-134.
136 Valdorf-Hansen F. Coagulability in diabetics. Acta med. Scand, Suppl 1976; 476: 147-157.
137 Voisin Ph, Rouselle D, Duimont C, Drouin P, Stoltz J. F. Evolution of beta-TG level in diabetic patients undergoing artifical pancreas treatment. Thrombos. Haemostas. Abstr 1981; 46: 440
138 Voisin Ph, Rousselle D, Drouin P, Stoltz J. F. Betathromboglobulin levels in diabetes mellitus: influence of degenerative lesions and glycemie regulation using an artificial pancreas. Thrombos. Res 1983; 30: 245-255.
139 Wu K. K, Hoak J. C. A new method for the qualitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; 2: 924-926.
140 Zahavi J, Jones N. A. G, Betteridge D. J, Leyton J, Galton D. J, Clark S. E, Kakkar V. V. Platelet factor 4, ß-thromboglobu-lin, malondialdehyde formation and blood lipids in patients with diabetes mellitus. Thromb. Haemostas 1979; 42: 334
141 Zahavi M, Zahavi J, Kakkar V. V. Modulation of platelet adenosine 3’, 5’ cyclic monophosphate in diabetes mellitus. Haemostasis 1982; 12: 90
142 Ziboh V. A, Maruta H, Lord J, Cagle W. D, Lucky W. Increased biosynthesis of thromboxane A2 by diabetic platelets. Eur. J. clin. Invest 1979; 9: 223-228.
143 Ziemen M, Krzywanek H. J, Coutandin K, Friedrich J, Breddin K. PARD, eine prospektive Studie zur Erfassung von Risikofaktoren bei Diabetikern. In Müller-Wiefei H, Barras J. P, Ehringer H, Krüger M. (Hrsg) Mikrozirkulation und Blutrheologie. Therapie der peripheren arteriellen Verschlußkrankheit G. Witzstrock; Baden-Baden – New York: 1980: 309-311.